Anti-RALY monoclonal antibody

Pre-made anti-RALY monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RALY/RALY products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1470-Ab-1/ GM-Tg-hg-IP1470-Ab-2Anti-Human RALY monoclonal antibodyHuman
GM-Tg-rg-IP1470-Ab-1/ GM-Tg-rg-IP1470-Ab-2Anti-Rat RALY monoclonal antibodyRat
GM-Tg-mg-IP1470-Ab-1/ GM-Tg-mg-IP1470-Ab-2Anti-Mouse RALY monoclonal antibodyMouse
GM-Tg-cynog-IP1470-Ab-1/ GM-Tg-cynog-IP1470-Ab-2Anti-Cynomolgus/ Rhesus macaque RALY monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1470-Ab-1/ GM-Tg-felg-IP1470-Ab-2Anti-Feline RALY monoclonal antibodyFeline
GM-Tg-cang-IP1470-Ab-1/ GM-Tg-cang-IP1470-Ab-2Anti-Canine RALY monoclonal antibodyCanine
GM-Tg-bovg-IP1470-Ab-1/ GM-Tg-bovg-IP1470-Ab-2Anti-Bovine RALY monoclonal antibodyBovine
GM-Tg-equg-IP1470-Ab-1/ GM-Tg-equg-IP1470-Ab-2Anti-Equine RALY monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1470-Ab-1/ GM-Tg-hg-IP1470-Ab-2; GM-Tg-rg-IP1470-Ab-1/ GM-Tg-rg-IP1470-Ab-2;
GM-Tg-mg-IP1470-Ab-1/ GM-Tg-mg-IP1470-Ab-2; GM-Tg-cynog-IP1470-Ab-1/ GM-Tg-cynog-IP1470-Ab-2;
GM-Tg-felg-IP1470-Ab-1/ GM-Tg-felg-IP1470-Ab-2; GM-Tg-cang-IP1470-Ab-1/ GM-Tg-cang-IP1470-Ab-2;
GM-Tg-bovg-IP1470-Ab-1/ GM-Tg-bovg-IP1470-Ab-2; GM-Tg-equg-IP1470-Ab-1/ GM-Tg-equg-IP1470-Ab-2
Products NameAnti-RALY monoclonal antibody
Formatmab
Target NameRALY
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RALY monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1470-Ag-1Recombinant multi-species RALY/ HNRPCL2/ P542 protein


    Target information

    Target IDGM-IP1470
    Target NameRALY
    Gene ID22913,19383,296301,713317,485845,101089932,504640
    Gene Symbol and SynonymsHNRPCL2,Merc,P542,RALY
    Uniprot AccessionQ9UKM9
    Uniprot Entry NameRALY_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125970
    Target ClassificationN/A

    The target: RALY, gene name: RALY, also named as HNRPCL2, P542. This gene encodes a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family. This protein may play a role in pre-mRNA splicing and in embryonic development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.